Hypoxia-inducible factor 2 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein
Hypoxia-inducible factor 2 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein
复制标题
DOI:
10.1002/hep.29754
复制
发表时间:
2018-06-01
期刊:
影响因子:
13.5
通讯作者:
Parola, Maurizio
中科院分区:
文献类型:
--
作者:
Morello, Elisabetta;Sutti, Salvatore;Parola, Maurizio
Mechanisms underlying progression of nonalcoholic fatty liver disease (NAFLD) are still incompletely characterized. Hypoxia and hypoxia-inducible factors (HIFs) have been implicated in the pathogenesis of chronic liver diseases, but the actual role of HIF-2 in the evolution of NAFLD has never been investigated in detail. In this study, we show that HIF-2 is selectively overexpressed in the cytosol and the nuclei of hepatocytes in a very high percentage (>90%) of liver biopsies from a cohort of NAFLD patients at different stages of the disease evolution. Similar features were also observed in mice with steatohepatitis induced by feeding a methionine/choline-deficient diet. Experiments performed in mice carrying hepatocyte-specific deletion of HIF-2 and related control littermates fed either a choline-deficient L-amino acid-defined or a methionine/choline-deficient diet showed that HIF-2 deletion ameliorated the evolution of NAFLD by decreasing parenchymal injury, fatty liver, lobular inflammation, and the development of liver fibrosis. The improvement in NAFLD progression in HIF-2-deficient mice was related to a selective down-regulation in the hepatocyte production of histidine-rich glycoprotein (HRGP), recently proposed to sustain macrophage M1 polarization. In vitro experiments confirmed that the up-regulation of hepatocyte HRGP expression was hypoxia-dependent and HIF-2-dependent. Finally, analyses performed on specimens from NAFLD patients indicated that HRGP was overexpressed in all patients showing hepatocyte nuclear staining for HIF-2 and revealed a significant positive correlation between HIF-2 and HRGP liver transcript levels in these patients. Conclusions: These results indicate that hepatocyte HIF-2 activation is a key feature in both human and experimental NAFLD and significantly contributes to the disease progression through the up-regulation of HRGP production. (Hepatology 2018;67:2196-2214).